What do systematic reviews say?

FLUPENTHIXOL DECANOATE vs GENERAL ORAL ANTIPSYCHOTICS

It is very uncertain whether FLUPENTHIXOL DECANOATE changes adverse effects: general ‐ movement disorders ‐ requiring… compared with ORAL ANTIPSYCHOTICS (very low certainty).

• Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
  RR 1.19 [0.77, 1.83]
  1 study · 60 participants
  Very low

FLUPENTHIXOL DECANOATE vs other depot antipsychotic drugs

FLUPENTHIXOL DECANOATE showed no clear difference in adverse effects: general ‐ movement disorders ‐ requiring… compared with OTHER DEPOT ANTIPSYCHOTICS (low certainty).

• Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
  RR 1.38 [0.75, 2.52]
  3 studies · 102 participants
  Low

FLUPENTHIXOL DECANOATE HIGH DOSE vs FLUPENTHIXOL DECANOATE STANDARD DOSE (˜40 mg/IM)

• Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 47 participants
  Very low

FLUPENTHIXOL DECANOATE VERY LOW (˜6 mg/IM) DOSE vs FLUPENTHIXOL DECANOATE LOW DOSE (˜9 mg/IM)

The review found no eligible studies for this question.

• Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found